BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
26.49
+0.28 (1.07%)
Dec 20, 2024, 4:00 PM EST - Market closed
BridgeBio Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 5,006 | 7,023 | 1,139 | 2,455 | 8,716 | 4,331 | |
| Market Cap Growth | 11.74% | 516.56% | -53.61% | -71.83% | 101.23% | - | |
| Enterprise Value | 6,470 | 8,229 | 2,271 | 3,264 | 8,544 | 3,859 | |
| Last Close Price | 26.49 | 40.37 | 7.62 | 16.68 | 71.11 | 35.05 | |
| PS Ratio | 22.18 | 754.92 | 14.67 | 35.22 | 1056.59 | 106.79 | |
| PB Ratio | -3.93 | -5.23 | -0.91 | -2.84 | 80.79 | 9.10 | |
| P/TBV Ratio | - | - | - | - | 150.52 | 10.60 | |
| EV/Sales Ratio | 29.71 | 884.51 | 29.25 | 46.81 | 1035.70 | 95.14 | |
| Debt / Equity Ratio | -1.42 | -1.30 | -1.38 | -1.99 | 4.60 | 0.19 | |
| Asset Turnover | 0.33 | 0.02 | 0.09 | 0.08 | 0.01 | 0.07 | |
| Quick Ratio | 1.93 | 3.04 | 4.03 | 6.34 | 6.35 | 9.09 | |
| Current Ratio | 3.19 | 3.32 | 4.52 | 6.58 | 6.72 | 9.42 | |
| Return on Equity (ROE) | - | - | - | - | -173.15% | -67.64% | |
| Return on Assets (ROA) | -48.88% | -64.08% | -35.80% | -41.75% | -44.42% | -30.35% | |
| Return on Capital (ROIC) | -61.30% | -85.54% | -43.72% | -48.94% | -50.63% | -33.29% | |
| Earnings Yield | -8.77% | -9.16% | -42.24% | -22.91% | -5.15% | -6.02% | |
| FCF Yield | -9.02% | -7.53% | -37.25% | -20.82% | -4.67% | -5.92% | |
| Buyback Yield / Dilution | -16.50% | -10.39% | -2.16% | -22.34% | -12.27% | -70.15% | |
| Total Shareholder Return | -16.50% | -10.39% | -2.16% | -22.34% | -12.27% | -70.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.